These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27048353)

  • 1. Pharmacologic Treatment of Pediatric Hypertension.
    Dhull RS; Baracco R; Jain A; Mattoo TK
    Curr Hypertens Rep; 2016 Apr; 18(4):32. PubMed ID: 27048353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hypertension in the young: role of antihypertensive medications.
    Flynn JT
    J Cardiovasc Pharmacol; 2011 Aug; 58(2):111-20. PubMed ID: 21242810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor blockers for management of hypertension.
    Catanzaro DF; Frishman WH
    South Med J; 2010 Jul; 103(7):669-73. PubMed ID: 20531060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of arterial hypertension. Clinical and pharmacological considerations].
    Silva Orrego P; Vera TV; Gual Julia JM; Gabbai F
    Arch Inst Cardiol Mex; 1987; 57(5):423-31. PubMed ID: 2892470
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatment of chronic pediatric hypertension.
    Robinson RF; Nahata MC; Batisky DL; Mahan JD
    Paediatr Drugs; 2005; 7(1):27-40. PubMed ID: 15777109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of arterial hypertension].
    Saragoça MA
    Rev Assoc Med Bras (1992); 1992; 38(3):159-68. PubMed ID: 1340367
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension in the elderly.
    Coodley EL
    Angiology; 1985 Jan; 36(1):45-52. PubMed ID: 2862811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The characteristics of the antihypertensive treatment of diabetes mellitus patients].
    Glezer GA
    Ter Arkh; 1993; 65(10):32-4. PubMed ID: 7905207
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive drugs for CVD.
    Weir MR
    J Fam Pract; 2006 Oct; 55(10):889-91; author reply 891-2. PubMed ID: 17089475
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazide diuretics in the treatment of hypertension: an update.
    Salvetti A; Ghiadoni L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S25-9. PubMed ID: 16565243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
    Lazich I; Bakris GL
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):471-5. PubMed ID: 21709549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.
    Miller K
    Drugs; 1994 Dec; 48(6):868-87. PubMed ID: 7533695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 20. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis.
    Bradley HA; Wiysonge CS; Volmink JA; Mayosi BM; Opie LH
    J Hypertens; 2006 Nov; 24(11):2131-41. PubMed ID: 17053529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.